Skip to content

What we’re about

Women make up over half the global population — yet until recently,
most health research wasn’t designed with women in mind.

Over 70% of participants in early-stage clinical trials are male,
leaving women’s biology under-represented.

Autoimmune diseases affect women 3 to 4 times more than men,
yet tailored treatment options remain limited.

Only 4% of biopharma R&D is focused on female-specific
conditions.

Two-thirds of Alzheimer’s patients are women, yet the reasons
are still poorly understood.

Menopause research is decades behind, despite affecting every
woman who lives long enough.

We’re still catching up. But that’s exactly why this moment matters.

Upcoming events

1

See all

Group links

Organizers

Members

1
See all